Photocontact dermatitis and chloracne: Two major occupational and environmental skin diseases induced by different actions of halogenated chemicals

Journal of Dermatological Science

Volumn 32, Issue 2, 2003, Pages 85-94

  Yamamoto, Osamu ^a   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chloracne; Occupation; Photocontact dermatitis; Skin diseases

Indexed keywords

2,3,7,8 TETRACHLOROBENZO 4 DIOXIN; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,5 TRICHLOROPHENOL; 2,4,5 TRICHLOROPHENOXYACETIC ACID; 3,4,3',4' TETRACHLOROAZOXYBENZENE; AROMATIC HYDROCARBON; BITHIONOL; BROMOCHLOROSALICYLANILIDE; CHLORHEXIDINE; CHLORO 2 PHENYLPHENOL; DIBROMSALAN; DICHLOROPHEN; FENTICLOR; HALIDE; HEXACHLOROPHENE; MELANIN; POLYBROMINATED BIPHENYL; POLYBROMINATED DIBENZOFURAN; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZOFURAN; POLYCHLORINATED NAPHTHALENE; POLYCHROMONAPHTHALENE; RETINOID; SALICYLANILIDE DERIVATIVE; TETRACHLORSALAN; TRIBROMSALAN; TRICLOCARBAN; TRICLOSAN; TRIFLUOROMETHYLDICHLOROCARBANILIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACNE; ANTIGEN PRESENTING CELL; CHLORACNE; CLINICAL FEATURE; COMEDO; CONJUGATION; CONTACT DERMATITIS; CONTACT SENSITIZATION; ENVIRONMENTAL DISEASE; EPIDERMIS CELL; EXPERIMENTAL MODEL; GENE CONTROL; GENETIC SUSCEPTIBILITY; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNE RESPONSE; INFUNDIBULUM; KERATINOCYTE; LANGERHANS CELL; NONHUMAN; OCCUPATIONAL DISEASE; PHOTOALLERGY; PHOTODERMATOSIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SEBACEOUS GLAND; SEBUM; SKIN DISEASE; T LYMPHOCYTE; ULTRAVIOLET A RADIATION;

EID: 0037824419     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00097-5     Document Type: Review

References (73)

1. Zugerman C. Dermatology in the workplace. Am. Fam. Phys. 26:1982;103-109.
2. Wilkinson D.S. Photodermatitis due to tetrachlorosalicylanilide. Br. J. Dermatol. 73:1961;213-219.
3. Harber L.C., Harris H., Baer R.L. Photoallergic contact dermatitis due to halogenated salicylanilides and related compounds. Arch. Dermatol. 94:1966;255-262.
4. Epstein J.H., Wepper K.D., Maibach H.I. Photocontact dermatitis to halogenated salicylanilides and related compounds: a clinical and histological review of 26 patients. Arch. Dermatol. 97:1968;236-244.
5. Bosca F., Miranda M.A. Photosensitizing drugs containing the benzophenone chromophore. J. Photochem. Photobiol. B. 43:1998;1-26.
6. Fujita H., Matsuo I. Type I lipid photo-oxidation by the nonsteroidal anti-inflammatory drug suprofen: a possible key to its photosensitivity. Photodermatol. Photoimmunol. Photomed. 9:1993;203-208.
7. Epstein J.H. Photoallergy: a review. Arch. Dermatol. 106:1972;741-747.
8. Willis I., Kligman A.M. The mechanism of photoallegic contact dermatitis. J. Invest. Dermatol. 51:1968;378-384.
9. Harber L.C., Targoynik S.E., Baer R.L. Contact photosensitivity patterns to halogenated salicylanilides in man ansguinea pigs. Arch. Dermatol. 96:1967;646-656.
10. Takigawa M., Miyachi Y. Mechanisms of contact photosensitivity in mice: I. T cell regulation of contact photosensitivity to tetrachlorosalicylanilide under the genetic restrictions of the major histocompatibility complex. J. Invest. Dermatol. 79:1982;108-115.
11. Maguire H.C., Kaidbey K. Experimental photoallergic contact dermatitis: a mouse model. J. Invest. Dermatol. 79:1982;147-152.
12. Miyachi Y., Takigawa M. Mechanisms of contact photosensitivity in mice. III. Predictive testing of chemicals with photoallergenic potential in mice. Arch. Dermatol. 119:1983;736-739.
13. Tokura Y., Satoh T., Yamada M., Takigawa M. Genetic control of contact photosensitivity to tetrachlorosalicylanilide. II. Igh comples controls the sensitivity induced by photohapten-modified spleen cells but not epidermal cells. Cell. Immunol. 135:1991;195-207.
14. Tokura Y., Takigawa M., Yamada M. Induction of contact photosensitivity to TCSA using photohapten-modified syngeneic spleen cells. Arch. Dermatol. Res. 280:1988;207-213.
15. Tokura Y. Immune responses to photohaptens: implications for the mechanisms of photosensitivity to exogenous agents. J. Dermatol. Sci. 23:(Suppl):2000;6-9.
16. Epling G.A., Wells J.L., Yoon U.C. Photohcemical transformations in salicylanilide photoallergy. Photochem. Photobiol. 2:1988;167-173.
17. Jenkins F.P., Welti D., Baines D. Photochemical reactions of tetrachlorosalicylanilide. Nature. 201:1964;827-828.
18. Kochevar I.E., Harber L.C. Photoreactions of 3,3′4′,5-tetrachlorosalicylanilide with proteins. J. Invest. Dermatol. 68:1977;151-156.
19. Tokura Y., Nishijima T., Yagi H., Furukawa F., Takigawa M. Photohaptenic properties of fluoroquinolones. Photochem. Photobiol. 64:1996;838-844.
20. Tokura Y., Seo N., Yagi H., Furukawa F., Takigawa M. Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vβ13 by immune T cells that recognize fluoroquinolone-photomodified cells. J. Immunol. 160:1998;3719-3728.
21. Tokura Y., Ogai M., Yagi H., Takigawa M. Afloqualone photosensitivity: immunogenicity of afloqualone-photomodified epidermal cells. Photochem. Photobiol. 60:1994;262-267.
22. Tokura Y., Yagi H., Satoh T., Takigawa T. Inhibitory effect of melanin pigment on sensitization and elicitation of murine contact photosensitivity: mechanism of low responsiveness in C57BL/10 background mice. J. Invest. Dermatol. 101:1993;673-678.
23. Tokura Y., Takigawa M. Immunological mechanisms of contact photosensitivity. Eur. J. Dermatol. 3:1993;87-91.
24. Gerberick G.F., Ryan C.A., Fletcher E.R., Hoeard A.D., Robinson M.K. Increased number of dendritic cells in draining lymph nodes accompanies the generation of contact photosensitivity. J. Invest. Dermatol. 96:1991;355-361.
25. Miyachi Y., Imamura S., Tokura Y., Takigawa M. Mechanisms of contact photosensitivity in mice. VII. Diminished elicitation by reserpine and defective expression in mast cell-deficient mice. J. Invest. Dermatol. 87:1986;39-41.
26. Tokura Y., Satoh T., Takigawa M., Yamada M. Genetic control of contact photosensitivity to tetrachlorosalicylanilide. I. Preferential activation of suppressor T cells in low responder H-2k mice. J. Invest. Dermatol. 94:1990;471-476.
27. Yagi H., Tokura Y., Wakita H., Furukawa F., Takigawa M. TCRVβ7+Th2 cells mediate UVB-induced suppression of murine contact photosensitivity by releasing IL-10. J. Immunol. 156:1996;1824-1831.
28. Suzuki K., Yamazaki S., Tokura Y. Expression of T-cell cytokines in challenged skin of murine allergic contact photosensitivity: low responsiveness is associated with induction of Th2 cytokines. J. Dermatol. Sci. 23:2000;138-144.
29. Nishijima T., Tokura Y., Imokawa G., Takigawa M. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells. J. Dermatol. Sci. 19:1999;202-207.
30. Aiba S., Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:1990;2791-2796.
31. Herxheimer K. Über Chlorakne. Münch. Med. Wochenschr. 46:1899;278.
32. von Bettman S. Chlorakne ein besondere Form von profssioneller Hauterkrankung. Disch. Med. Wochenschr. 27:1901;437.
33. Fowler J.F. Jr. Acne, folliculitis, and chloracne. Adams R.M. Occupational skin disease. third ed: 1999;135-141 W.B. Saunders, Philadelphia.
34. Crow K.D. Chloracne. An up to date assessment. Ann. Occup. Hyg. 21:1978;297-298.
35. Taylor J.S. Environmental chloracne: update and overview. Ann. New York Acad. Sci. 320:1979;295-307.
36. Shelley W.B., Kligman A.M. The experimental production of acne by penta- and hexachloronaphthalenes. Arch. Dermatol. 75:1957;689-695.
37. Tindall J.P. Chloracne and chloracnegens. J. Am. Acad. Dermatol. 13:1985;539-558.
38. Crow K.D. Chloracne and its potential clinical implications. Clin. Exp. Dermatol. 6:1981;243-257.
39. Zugerman C. Chloracne. Clinical manifestation and etiology. Contact Dermatitis. 8:1990;209-213.
40. Goldman P.J. Severe acute chloracne, a mass intoxication by 2,3,6,7-tetrachlorodibenzo-p-dioxin. Hautarzt. 24:1973;149-152.
41. Suskind R.R. The hallmark of dioxin intoxication. Scand. J. Work Environ. Health. 11:1985;165-171.
42. Crow K.D. Chloracne: an up-to-date assessment. Ann. Occup. Hyg. 21:1978;297-298.
43. Hambrick G.S. The effect of substituted naphthalenes on the pilosebaceous apparatus of rabbit and man. J. Invest. Dermatol. 28:1957;89-103.
44. Knutson J.C., Poland A. Response of murine epidermis to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin: interaction of the Ah and hr loci. Cell. 30:1982;225-234.
45. Poland A., Knutson J.C., Glover E. Histologic changes produced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in the skin of mice carrying mutations that affect the integment. J. Invest. Dermatol. 83:1984;454-459.
46. Kociba R.J., Schwetz B.A. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Drug Metab. Rev. 13:1982;387-406.
47. Safe S. Polychlorinatedbiphenyls(PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21:1990;51-88.
48. Johnson E.S. Human exposure to 2,3,7,8-TCDD and risk of cancer. Crit. Rev. Toxicol. 21:1992;451-463.
49. Poland A., Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22:1982;517-554.
50. Birnbaum L.S. The mechanism of dioxin toxicity: relationship to risk assessment. Environ. Health Perspect. 102:(suppl 19):1994;157-167.
51. Rozman K. A critical view of the mechanism(s) of toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Implications for human safety assessment. Dermatosen. 37:1989;81-92.
52. Okey A.B., Riddick D.S., Harper P.A. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70:1994;1-22.
53. Hudson L.G., Shaikh R., Tscano W.A. Jr, Greenlee W.F. Induction of 7-ethoxycoumarin O-demethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochem. Biophys. Res. Commun. 115:1983;611-617.
54. Harper P.A., Golas C.L., Okey A.B. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin and benzo(a)anthracene in the human A431 squamous cell carcinoma line. Cancer Res. 48:1988;2388-2395.
55. Nebert D.W., Eisen H.J., Negishi M., Lang M., Hjelmeland L., Okey A. Genetic mechanisms controlling the induction of polysubstrate monooxygenase (P-450) activities. Annu. Rev. Pharmacol. Toxicol. 21:1981;431-462.
56. Milstone L.M., La Vigne J.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. J. Invest. Dermatol. 82:1984;532-534.
57. Hèbert C.D., Cao Q.L., Birnbaum L.S. Inhibition of high-density growth arrest in human squamous carcinoma cell by 2,3,7,8-trichlorodibenzo-p-dioxin (TCDD). Carcinogenesis. 11:1990;1335-1342.
58. Berkers J.A.M., Hassing I., Spenkelink B., Brouwer A., Blaauboer B.J. Interactive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoids on proliferation and differentiation in cultured human keratinocytes: quantification of cross-linked envelope formation. Arch. Toxicol. 69:1995;368-378.
59. Rice R.H., Cline P.R. Opposing effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone on growth and differentiation of cultured malignant human keratinocytes. Carcinogenesis. 5:1984;367-371.
60. Van Pelt F.N.A.M., Hassing I.G.A., Stelling M.A., Seinen W., Blaauboer B.J. Induction of terminal differentiation in cultured human keratinocytes by polychlorinated aromatic hydrocarbons as measured by cell size analysis. Toxicol. Appl. Pharmacol. 113:1992;240-245.
61. Osborne R., Greenlee W.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. Toxicol. Appl. Pharmacol. 77:1985;434-443.
62. Hudson L.G., Toscano W.A. Jr, Greenlee W.F. Regulation of epidermalgrowth factor binding in human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 77:1985;251-259.
63. Loertscher J.A., Sattler C.A., Allen-Hoffmann B.L. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol. Appl. Pharmacol. 175:2001;121-129.
64. Thunberg T., Ahlborg U.G., Hakansson H., Krantz C., Monier M. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the hepatic storage of retinal in rats with different dietary supplies of vitamin A (retinal). Arch. Toxicol. 45:1980;278-285.
65. Coenraads P.J., Brouwer A., Olie K., Tang N.J. Chloracne. Some recent issues. Dermatol. Clin. 12:1994;569-576.
66. Fuchs E., Green H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell. 25:1987;617-625.
67. Thunberg T. Effect of TCDD on vitamin A and its relation to TCDD-toxicity, In: Poland A, Kimbrough RD, editors. Banbury Report 18: Biologic Mechanisms of Dioxin Action Meeting. Cold Spring Harbor, NY, 1984. pp. 333-43.
68. Pleweg G. Lokalbehandlung der Chloracne (Halowaxacne) mit Vitamin A säure. Hautarzt. 21:1970;465-470.
69. Scerri L., Zaki I., Millard L.G. Severe halogen acne due to a trifluoromethylpyrazole derivative and its resistance to isotretinoin. Br. J. Dermatol. 132:1995;144-148.
70. Puhvel S.M., Sakamoto M., Ertl D.C., Reisner R.M. Hairless mice as models for chloracne: a study of cutaneous changes induced by topical application of established chloracnegens. Toxicol. Appl. Pharmacol. 64:1982;492-503.
71. Inagami K., Koga T., Kikuchi M., Hashimoto M., Takahashi H., Wada K. Experimental study of hairless mice following administration of rice oil used by a δ Yusho patient. Fukuoka. Acta Medica. 60:1969;548-553.
72. Nebert D.W., Gielen J.E. Genetic regulation of aryl hydrocarbons hydroxylase induction in the mouse. Fed. Proc. 31:1972;1315-1327.
73. Panteleyev A.A., Thiel R., Wanner R., Zhang J., Roumak V.S., Paus R., Neubert D., Henz B.M., Rosenbach T. 2,3,7,8-Trichlorodibenzo-p-dioxin (TCDD) affects keratin 1 and keratin 17 gene expression and differentially induces keratinization in hairless mouse skin. J. Invest. Dermatol. 108:1997;330-335.